Arterial Thromboembolism in Patients With AF and CHA₂DS₂-VASc Score 0-2 With and Without Cancer.

ABSTRACT:

Background

It is unclear whether newly diagnosed cancer adds to the risk of arterial thromboembolism (ATE) in patients with atrial fibrillation/flutter (AF). This is especially relevant for AF patients with low to intermediate CHA₂DS₂-VASc scores in whom the risk-benefit ratios between ATE and bleeding are delicately balanced.

Objectives

The objectives were to evaluate the ATE risk in AF patients with a CHA₂DS₂-VASc score of 0 to 2 with and without cancer.

Methods

A population-based retrospective cohort study was performed. Patients with a CHA₂DS₂-VASc score of 0 to 2 not receiving anticoagulation at cancer diagnosis (or the matched index date) were included. Patients with embolic ATE or cancer before s

SUBMITTER: Leader A 

PROVIDER: S-EPMC10152191 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature